Corticobasal degeneration

Lancet Neurology

Volumn 3, Issue 12, 2004, Pages 736-743

  Mahapatra, Robert K ^a   Edwards, Mark J ^a   Schott, Jonathan M ^a   Bhatia, Kailash P ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMANTADINE; ANTICONVULSIVE AGENT; BACLOFEN; BOTULINUM TOXIN; BROMOCRIPTINE MESILATE; CHOLINERGIC RECEPTOR BLOCKING AGENT; CHOLINESTERASE INHIBITOR; CLONAZEPAM; DANTROLENE; DOPAMINE RECEPTOR STIMULATING AGENT; LEVODOPA; PROPRANOLOL; SELEGILINE; SEROTONIN UPTAKE INHIBITOR;

APRAXIA; CADAVER; CLINICAL FEATURE; COGNITIVE DEFECT; CORTICOBASAL DEGENERATION; DEGENERATIVE DISEASE; DEMENTIA; DIFFERENTIAL DIAGNOSIS; DISEASE COURSE; DRUG MEGADOSE; DYSKINESIA; DYSPHAGIA; DYSTONIA; ELECTROPHYSIOLOGY; HISTOPATHOLOGY; HUMAN; MUSCLE RIGIDITY; PARKINSON DISEASE; PARKINSONISM; PRIORITY JOURNAL; REVIEW; SIDE EFFECT;

BASAL GANGLIA; CEREBRAL CORTEX; DIAGNOSIS, DIFFERENTIAL; HUMANS; NEURODEGENERATIVE DISEASES;

EID: 8844259542     PISSN: 14744422     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1474-4422(04)00936-6     Document Type: Review

References (72)

1. Rebeiz JJ, Kolodny EH, Richardson EP. Jr. Corticodentatonigral degeneration with neuronal achromasia. Arch Neurol. 18:1968;20-33
2. Case Records of the Massachussetts General Hospital. Case 38-1985: case of corticonigral degeneration with neuronal achromasia. N Eng J Med 1993; 329: 1560-1567.
3. Clark AW, Manz HJ, White CL, Lehmann J, Miller D, Coyle JT. Cortical degeneration with swollen chromatolytic neurons: its relationship to Pick's disease. J Neuropathol Exp Neurol. 45:1986;268-284
4. Watts RL, Williams RS, Growdon JV, Young RR, Haley EC, Beal MF. Cortico-basal ganglionic degeneration. Neurology. 35:1985;178
5. Riley DE, Lang AE, Lewis A, et al. Cortical-basal ganglionic degeneration. Neurology. 40:1990;1203-1212
6. Gibb WR, Luthert PJ, Marsden CD. Corticobasal degeneration. Brain. 112:1989;1171-1192
7. Wenning GK, Litvan I, Jankovic J, et al. Natural history and survival of 14 patients with corticobasal degeneration confirmed at postmortem examination. J Neurol Neurosurg Psychiatry. 64:1998;184-189
8. DePold Hohler A, Ransom BR, Chun MR, Troster AI, Samii A. The youngest reported case of corticobasal degeneration. Parkinsonism Relat Disord. 10:2003;47-50
9. Rinne JO, Lee MS, Thompson PD, Marsden CD. Corticobasal degeneration: a clinical study of 36 cases. Brain. 117:1994;1183-1196
10. Watts RL, Mirra SS, Richardson EP. Corticobasal ganglionic degeneration. Marsden CD, Fahn S. Movement disorders. 1994;282-299 Butterworths-Heinemann, Oxford
11. Schneider JA, Watts RL, Gearing M, Brewer RP, Mirra SS. Corticobasal degeneration: neuropathologic and clinical heterogeneity. Neurology. 48:1997;959-969
12. Watts RL, Brewer RP, Schneider JA, Mirra SS. Corticobasal degeneration. Watts RL, Koller WC. Movement disorders: neurologic principles and practice. 1997;611-621 McGraw-Hill, New York
13. Brown J, Lantos PL, Roques P, Fidani L, Rossor MN. Familial dementia with swollen achromatic neurons and corticobasal inclusion bodies: a clinical and pathological study. J Neurol Sci. 135:1996;21-30
14. Schrag A, Ben-Shlomo Y, Quinn NP. Prevalence of progressive supranuclear palsy and multiple system atrophy: a cross-sectional study. Lancet. 354:1999;1771-1775
15. Togasaki DM, Tanner CM. Epidemiologic aspects. Adv Neurol. 82:2000;53-59
16. Kompoliti K, Goetz CG, Boeve BF, et al. Clinical presentation and pharmacological therapy in corticobasal degeneration. Arch Neurol. 55:1998;957-961
17. Litvan I, Grimes DA, Lang AE. Phenotypes and prognosis: clinicopathologic studies of corticobasal degeneration. Adv Neurol. 82:2000;183-196
18. Vanek ZF, Jankovic J. Dystonia in corticobasal degeneration. Adv Neurol. 82:2000;61-67
19. Litvan I, Agid Y, Goetz C, et al. Accuracy of the clinical diagnosis of corticobasal degeneration: a clinicopathologic study. Neurology. 48:1997;119-125
20. Jacobs DH, Adair JC, Macauley B, Gold M, Gonzalez Rothi LJ, Heilman KM. Apraxia in corticobasal degeneration. Brain Cogn. 40:1999;336-354
21. Spatt J, Bak T, Bozeat S, Patterson K, Hodges JR. Apraxia, mechanical problem solving and semantic knowledge: contributions to object usage in corticobasal degeneration. J Neurol. 249:2002;601-608
22. Ozsancak C, Auzou P, Hannequin D. Dysarthria and orofacial apraxia in corticobasal degeneration. Mov Disord. 15:2000;905-910
23. Doody RS, Jankovic J. The alien hand and related signs. J Neurol Neurosurg Psychiatry. 55:1992;806-810
24. Barclay CL, Bergeron C, Lang AE. Arm levitation in progressive supranuclear palsy. Neurology. 52:1999;879-882
25. Josephs KA, Rossor MN. The alien limb. Pract Neurol. 4:2004;44-45
26. Graham NL, Bak TH, Hodges JR. Corticobasal degeneration as a cognitive disorder. Mov Disord. 18:2003;1224-1232
27. Lang AE. Corticobasal degeneration: selected developments. Mov Disord. 18:(suppl 6):2003;S51-56
28. Lang AE, Riley DE, Bergeron C. Cortical-basal ganglionic degeneration. Calne DB. Neurodegenerative diseases. 1994;877-894 WB Saunders, Philadelphia
29. Boeve BF, Lang AE, Litvan I. Corticobasal degeneration and its relationship to progressive supranuclear palsy and frontotemporal dementia. Ann Neurol. 54:(suppl 5):2003;S15-19
30. Stover NP, Watts RL. Corticobasal degeneration. Semin Neurol. 21:2001;49-58
31. Dubois B, Slachevsky A, Litvan I, Pillon B. The FAB: a Frontal Assessment Battery at bedside. Neurology. 55:2000;1621-1628
32. Bergeron C, Davis A, Lang AE. Corticobasal ganglionic degeneration and progressive supranuclear palsy presenting with cognitive decline. Brain Pathol. 8:1998;355-365
33. Grimes DA, Lang AE, Bergeron CB. Dementia as the most common presentation of cortical-basal ganglionic degeneration. Neurology. 53:1999;1969-1974
34. Sakurai Y, Hashida H, Uesugi H, et al. A clinical profile of corticobasal degeneration presenting as primary progressive aphasia. Eur Neurol. 36:1996;134-137
35. Kertesz A, Martinez-Lage P, Davidson W, Munoz DG. The corticobasal degeneration syndrome overlaps progressive aphasia and frontotemporal dementia. Neurology. 55:2000;1368-1375
36. Mathuranath PS, Xuereb JH, Bak T, Hodges JR. Corticobasal ganglionic degeneration and/or frontotemporal dementia? A report of two overlap cases and review of literature. J Neurol Neurosurg Psychiatry. 68:2000;304-312
37. Neary D, Snowden JS, Gustafson L, et al. Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria. Neurology. 51:1998;1546-1554
38. Kertesz A, Munoz D. Relationship between frontotemporal dementia and corticobasal degeneration/progressive supranuclear palsy. Dement Geriatr Cog Disord. 17:2004;282-286
39. Cummings JL, Litvan I. Neuropsychiatric aspects of corticobasal degeneration. Adv Neurol. 82:2000;147-152
40. Rivaud-Pechoux S, Vidailhet M, Gallouedec G, Litvan I, Gaymard B, Pierrot-Deseilligny C. Longitudinal ocular motor study in corticobasal degeneration and progressive supranuclear palsy. Neurology. 54:2000;1029-1032
41. Shiozawa M, Fukutani Y, Sasaki K, et al. Corticobasal degeneration: an autopsy case clinically diagnosed as progressive supranuclear palsy. Clin Neuropathol. 19:2000;192-199
42. Tang-Wai DF, Josephs KA, Boeve BF, Dickson DW, Parisi JE, Petersen RC. Pathologically confirmed corticobasal degeneration presenting with visuospatial dysfunction. Neurology. 61:2003;1134-1135
43. Litvan I, Grimes DA, Lang AE, et al. Clinical features differentiating patients with postmortem confirmed progressive supranuclear palsy and corticobasal degeneration. J Neurol. 246:(suppl 2):1999;I1-5
44. Josephs KA, Dickson DW. Diagnostic accuracy of progressive supranuclear palsy in the Society for Progressive Supranuclear Palsy brain bank. Mov Disord. 18:2003;1018-1026
45. Doran M, du Plessis DG, Enevoldson TP, Fletcher NA, Ghadiali E, Larner AJ. Pathological heterogeneity of clinically diagnosed corticobasal degeneration. J Neurol Sci. 15:2003;127-134
46. Lleo A, Rey MJ, Castellvi M, Ferrer I, Blesa R. Asymmetric myoclonic parietal syndrome in a patient with Alzheimer's disease mimicking corticobasal degeneration. Neurologia. 17:2002;223-226
47. Horoupian DS, Wasserstein PH. Alzheimer's disease pathology in motor cortex in dementia with Lewy bodies clinically mimicking corticobasal degeneration. Acta Neuropathol (Berl). 98:1999;317-322
48. Bhatia KP, Lee MS, Rinne JO, et al. Corticobasal degeneration look-alikes. Adv Neurol. 82:2000;169-182
49. Boeve BF, Maraganore DM, Parisi JE, et al. Pathologic heterogeneity in clinically diagnosed corticobasal degeneration. Neurology. 53:1999;795-800
50. Josephs KA, Holton JL, Rossor MN, et al. Neurofilament inclusion body disease: a new proteinopathy? Brain. 126:2003;2291-2303
51. Savoiardo M, Grisoli M, Girotti F. Magnetic resonance imaging in CBD, related atypical parkinsonian disorders, and dementias. Adv Neurol. 82:2000;197-208
52. Soliveri P, Monza D, Paridi D, et al. Cognitive and magnetic resonance imaging aspects of corticobasal degeneration and progressive supranuclear palsy. Neurology. 53:1999;502-507
53. Monza D, Ciano C, Scaioli V, et al. Neurophysiological features in relation to clinical signs in clinically diagnosed corticobasal degeneration. Neurol Sci. 24:2003;16-23
54. Takeda M, Tachibana H, Okuda B, Kawabata K, Sugita M. Electrophysiological comparison between corticobasal degeneration and progressive supranuclear palsy. Clin Neurol Neurosurg. 100:1998;94-98
55. 123I]bCIT SPECT in multiple system atrophy, progressive supranuclear palsy, and corticobasal degeneration. Mov Disord. 15:2000;1158-1167
56. Marshall V, Grosset D. Role of dopamine transporter imaging in routine clinical practice. Mov Disord. 18:2003;1415-1423
57. Brooks DJ. Functional imaging studies in corticobasal degeneration. Adv Neurol. 82:2000;209-215
58. Gerhard A, Watts J, Trender-Gerhard I, et al. In vivo imaging of microglial activation with [11C] (R)-PK11195 PET in corticobasal degeneration. Mov Disord. 19:2004;1221-1226
59. Henkel K, Karitzky J, Schmind M, et al. Imaging of activated microglia with PET and [11C]PK11195 in corticobasal degeneration. Mov Disord. 19:2004;817-821
60. Dickson DW, Bergeron C, Chin SS, et al. Office of Rare Diseases neuropathologic criteria for corticobasal degeneration. J Neuropathol Exp Neurol. 61:2002;935-946
61. Smith TW, Lippa CF, de Girolami U. Immunocytochemical study of ballooned neurons in cortical degeneration with neuronal achromasia. Clin Neuropathol. 11:1992;28-35
62. Dickson DW, Liu WK, Ksiezak-Reding H, Yen SH. Neuropathologic and molecular considerations. Adv Neurol. 82:2000;9-27
63. Feany MB, Dickson DW. Neurodegenerative disorders with extensive tau pathology: a comparative study and review. Ann Neurol. 40:1996;139-148
64. Morris HR, Lees AJ, Wood NW. Neurofibrillary tangle parkinsonian disorders - tau pathology and tau genetics. Mov Disord. 14:1999;731-736
65. Arai T, Ikeda K, Akiyama H, et al. Distinct isoforms of tau aggregated in neurons and glial cells in brains of patients with Pick's disease, corticobasal degeneration and progressive supranuclear palsy. Acta Neuropathol (Berl). 101:2001;167-173
66. Forman MS, Zhukareva V, Bergeron C, et al. Signature tau neuropathology in gray and white matter of corticobasal degeneration. Am J Pathol. 160:2002;2045-2053
67. Di Maria E, Tabaton M, Vigo T, et al. Corticobasal degeneration shares a common genetic background with progressive supranuclear palsy. Ann Neurol. 47:2000;374-377
68. Houlden H, Baker M, Morris HR, et al. Corticobasal degeneration and progressive supranuclear palsy share a common tau haplotype. Neurology. 56:2001;1702-1706
69. Frucht S, Fahn S, Chin S, Dhawan V, Eidelberg D. Levodopa-induced dyskinesias in autopsy-proven cortical-basal ganglionic degeneration. Mov Disord. 15:2000;340-343
70. Yasuoka T, Ikeda M, Maki N, Hokoishi K, Komori K, Tanabe H. A case of corticobasal degeneration of which movemental disturbances were improved by administration of amantadine. No To Shinkei. 53:2001;781-785
71. Cordivari C, Misra VP, Catania S, Lees AJ. Treatment of dystonic clenched fist with botulinum toxin. Mov Disord. 16:2001;907-913
72. Imamura T, Takanashi M, Hattori N, et al. Bromocriptine treatment for perseveration in demented patients. Alzheimer Dis Assoc Disord. 12:1998;109-113